Category: MARKET REPORTS

Developed by Janssen Biotech, the blockbuster therapeutic antibody STELARA (INN: ustekinumab) is an approved human interleukin-12 and interleukin-23 antagonist indicated for the treatment of moderate to severe plaque psoriasis in adults and pediatric patients (6 years or older) who are candidates for phototherapy or systemic therapy, active psoriatic arthritis in adults, as well as for adult patients with moderately to severely active Crohn's disease and moderately to severely active ulcerative colitis. Stelara was approved in the US and EU in 2009. The Stelara patent expires September 2023 in the United States.

The global market for Colonoscopy Devices estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$2.2 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2022-2030.

The "ICU Beds Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The ICU beds market is set to grow from $2.02 billion in 2023 to $2.15 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth observed in the historical period can be attributed to several factors, including the aging population, technological advancements in healthcare, the development of healthcare infrastructure, and the increased demand for critical care services. These elements collectively contributed to the...

The "Cardiac Bio Implant Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering

The "Filter Needles Market Size, Share & Trends Analysis Report By Raw Material (Stainless Steel, Glass, Others), By End-use (Hospital, Clinics, Ambulatory Surgery Centers, Others), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering. The global filter needles market size is expected to reach USD 2.9 billion by 2030. The market is expected to expand at a CAGR of 7.5% from 2023 to 2030. The increasing geriatric population, technological advancements, and rising prevalence of chronic...

The global market for pain management drugs and devices was valued at $80.9 billion in 2022. The market is estimated to grow from $84.6 billion in 2023 at a compound annual growth rate (CAGR) of 5.4% to reach approximately $109.9 billion by the end of 2028. This report segments the global market by product, application and region.

The global market for Medical Imaging Equipment Services estimated at US$20.9 Billion in the year 2022, is projected to reach a revised size of US$29.7 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2022-2030.

The healthcare sector has witnessed remarkable changes in the last decade. There has been an increase in the usage of innovative and sensitive diagnostic tools, and this is resulting in advancements in healthcare facilities. The evolution of imaging technology has contributed to the development of better diagnoses and clinical interventions.

The global hernia mesh devices market size is expected to reach USD 8.32 billion by 2030, registering a CAGR of 6.7% during the forecast period. The growth is owing to an increase in the incidence of hernias, and the high adoption of meshes in surgeries due to factors such as reduced operative time, cost-effectiveness, reduced pain, and high availability of products in the market.